Skip to content

Anti-inflammatory drug could reduce heart disease risk in patients with HIV

Revised US labelling for darunavir/ritonavir recommends caution for patients with liver problems

Merck licenses fusion inhibitor to International Partnership for Microbicides

Evidence from large US cohort says anti-HIV therapy does not increase heart disease risk

Studies begin to define who will do best on bevirimat

South Africa: Question marks over ARV tender

Home-based HIV care in Uganda has excellent results

Concerns in US study over abacavir/3TC's potency in patients with a high viral load

Viral suppression improves kidney function in patients with poor baseline kidney function and low CD4 counts